Anti-HIV cream to begin trials
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.British scientists will announce today the launch of human trials of a ground-breaking gel which could prevent up to three million people a year becoming infected with HIV.
British scientists will announce today the launch of human trials of a ground-breaking gel which could prevent up to three million people a year becoming infected with HIV.
The anti-viral gel has been developed by the Medical Research Council and London's Imperial College with £17m of government money. It works by forming a protective barrier during sex which attacks the virus - which can lead to AIDS - before it has the chance to infect vulnerable cells.
Researchers will tell a conference in London that laboratory trials have proved successful and clinical trials will take place in five African countries.
Professor Jonathan Weber, of Imperial College, said that the drug could be applied by women before sex in the form of an ointment or cream in situations where the use of a condom is impossible.
Prof Weber said: "What we have done is set out to try to identify chemical compounds which will be safe and easy for women to use, which in the test-tube completely prevent HIV getting into cells."
Twelve thousand women will take part in the three-year trials in South Africa, Zambia, Cameroon, Tanzania and Uganda. Africa has been ravaged by AIDS over the last 20 years, with up to 40 per cent of adults infected in some countries. South Africa has the highest rate in the world with five million people infected.
Religious and cultural barriers have been blamed for many men in developing countries not using condoms.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments